Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2044-5385
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization ; volume:8 ; number:6 ; day:7 ; month:6 ; year:2018 ; pages:1-4 ; date:6.2018
Blood cancer journal ; 8, Heft 6 (7.6.2018), 1-4, 6.2018
- Creator
- Contributor
-
Tisi, Maria Chiara
Bartolomei, Francesca
Cuccaro, Annarosa
Maiolo, Elena
Alma, Eleonora
D’Alò, Francesco
Bellesi, Silvia
Rossi, Elena
Stefano, Valerio De
SpringerLink (Online service)
- DOI
-
10.1038/s41408-018-0096-1
- URN
-
urn:nbn:de:101:1-2018081305061696493261
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.1585, 12:55 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hohaus, Stefan
- Tisi, Maria Chiara
- Bartolomei, Francesca
- Cuccaro, Annarosa
- Maiolo, Elena
- Alma, Eleonora
- D’Alò, Francesco
- Bellesi, Silvia
- Rossi, Elena
- Stefano, Valerio De
- SpringerLink (Online service)
Other Objects (12)
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization
Venous anomalies and thromboembolism
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
Severe hyperkalemia requiring hospitalization: predictors of mortality
Venous thromboembolism : prevention and treatment
Heparin and Venous Thrombo-Embolism
Venous thromboembolism and cancer risk
Venous Thromboembolism Issues in Women
Venous Thromboembolism in COVID-19
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients
Factors Influencing Prescribers' Decision for Extending Venous Thromboembolism Prophylaxis in the Medical Patient Population following Hospitalization
Predicting Venous Thromboembolism in Primary Care
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization
Venous anomalies and thromboembolism
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
Severe hyperkalemia requiring hospitalization: predictors of mortality
Venous thromboembolism : prevention and treatment
Heparin and Venous Thrombo-Embolism
Venous thromboembolism and cancer risk
Venous Thromboembolism Issues in Women
Venous Thromboembolism in COVID-19
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients
Factors Influencing Prescribers' Decision for Extending Venous Thromboembolism Prophylaxis in the Medical Patient Population following Hospitalization
Predicting Venous Thromboembolism in Primary Care
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization
Venous anomalies and thromboembolism
Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
Severe hyperkalemia requiring hospitalization: predictors of mortality
Venous thromboembolism : prevention and treatment
Heparin and Venous Thrombo-Embolism
Venous thromboembolism and cancer risk
Venous Thromboembolism Issues in Women
Venous Thromboembolism in COVID-19
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients
Factors Influencing Prescribers' Decision for Extending Venous Thromboembolism Prophylaxis in the Medical Patient Population following Hospitalization